Atlas Trials

A Study on Mucosal Specific IgA Immunokinetics After Administration of Nasal Spray Live Attenuated Influenza Vaccine

Clinical trial NCT07545564 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07545564
Sponsor
Changchun BCHT Biotechnology Co.
Status
ENROLLING_BY_INVITATION
Phase
Phase 4
Study type
INTERVENTIONAL
Influenza
Start date
2026-04-09
Primary completion
2026-04-23
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.